Early research (Phase 1)UnknownNCT02456350
What this trial is testing
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
Who this might be right for
Chronic Lymphocytic LeukemiaAcute Lymphocytic LeukemiaLymphoma
Shenzhen Second People's Hospital 36